Quick answer: A thyroglobulin antibody test (TgAb) measures immune proteins that attack thyroglobulin, a protein your thyroid uses to make T3 and T4. Most labs set the upper normal limit at 1 IU/mL or below. Elevated TgAb is found in roughly 60 to 70 percent of people with Hashimoto’s thyroiditis and about 30 percent of those with Graves’ disease, and it also complicates thyroid cancer surveillance after thyroidectomy. A single elevated result does not diagnose a disease on its own, but alongside TSH, free T4, and TPO antibodies, it gives a clinician a much fuller picture of thyroid autoimmunity.
What is thyroglobulin, and why would your immune system attack it?
Thyroglobulin (Tg) is a large protein produced exclusively inside thyroid follicular cells. It serves as the scaffold on which iodine atoms are strung together to eventually form thyroid hormones. Under normal circumstances, Tg stays inside the gland and only tiny amounts leak into the bloodstream. When the thyroid is inflamed, damaged, or surgically removed, more Tg spills out, and in people with autoimmune thyroid disease, the immune system has already generated antibodies against it.
The antibodies themselves (TgAb) do not destroy thyroid cells directly the way TPO antibodies are thought to. What they do instead is interfere with the assay used to measure thyroglobulin levels, which is exactly why clinicians always order TgAb alongside thyroglobulin when monitoring differentiated thyroid cancer patients. A falsely suppressed Tg reading caused by undetected TgAb is one of the most common and dangerous errors in thyroid cancer follow-up. Beyond oncology, TgAb positivity signals an ongoing autoimmune process even when TSH is still normal, which can help explain unexplained fatigue, weight changes, or a nodular thyroid found on ultrasound.
Understanding the best biomarkers to test for thyroid health means knowing that TgAb rarely travels alone. It almost always needs TSH, free T4, and TPO Ab to be interpretable.
How thyroid autoimmunity actually damages the gland
The simplest way to actually get this done
Superpower is a full-body lab membership that runs 100+ biomarkers, has each result reviewed by a doctor, and tracks your numbers year over year (about $199/year). It is what we point readers to when they would rather get one clean, complete draw than chase single tests one at a time. Here is superpower reviewed in full.
Understanding why TgAb shows up helps you read the result. In Hashimoto’s thyroiditis, immune cells (mainly lymphocytes) infiltrate the thyroid and mount a slow, grinding attack on thyroid tissue over years. The antibodies measured in blood, TgAb and TPOAb, are markers of that process rather than its main weapons. The real destruction is driven largely by T-cells that gradually replace working thyroid tissue with scar and lymphocytic infiltrate. That is why the disease is usually silent for a long time: the gland has substantial reserve, and TSH stays normal until enough tissue is lost that hormone output finally starts to fall.
This slow timeline is the reason a positive antibody with a normal TSH is not a crisis. It is an early warning that the process has started, often years before symptoms. It also explains why antibody levels and symptom severity correlate so poorly. Two people with identical TgAb numbers can sit in very different places on the same slow curve, one with a fully compensating gland and one already sliding toward hypothyroidism. The antibody tells you the immune process is active. The TSH and free T4 tell you how much function you have left.
Thyroglobulin antibody normal range: the numbers labs actually use
Most US reference laboratories place the upper limit for TgAb at 1.0 IU/mL for the electrochemiluminescent immunoassay (ECLIA) platform, and Quest Diagnostics reports negative as less than 1.0 IU/mL. Labcorp uses a similar cutoff. Older radioimmunoassay methods used different units (international units per milliliter vs. arbitrary units), so a result from a decade-old printout may not map directly to today’s reference range.
| Assay platform | Negative (normal) | Borderline / equivocal | Positive |
|---|---|---|---|
| ECLIA (Roche, used by Quest) | <1.0 IU/mL | 1.0 to 2.0 IU/mL | >2.0 IU/mL |
| CMIA (Abbott, used by Labcorp) | <1.0 IU/mL | Not formally defined | ≥1.0 IU/mL |
| Immunoturbidimetric (some hospital labs) | <115 IU/mL | 115 to 200 IU/mL | >200 IU/mL |
The difference between platforms matters more than most people realize. A result of 1.5 IU/mL on an ECLIA is mildly positive. On an immunoturbidimetric assay with a 115 IU/mL cutoff, 1.5 IU/mL is solidly negative. Always compare results within the same lab and platform when tracking trends over time. Switching labs mid-surveillance is a classic source of false alarm and unnecessary repeat biopsies.
One subtlety worth knowing: a weakly positive TgAb in the 1 to 4 IU/mL range appears in about 10 percent of the general US population with no thyroid disease at all, especially in women over 50. The clinical weight of a mildly elevated result depends entirely on context, not just the number.
What does a high TgAb mean?
Elevated TgAb is most commonly a sign of autoimmune thyroid disease, particularly Hashimoto’s thyroiditis. The three main scenarios where a high result matters are listed below.
Hashimoto’s thyroiditis
Hashimoto’s is the most common cause of hypothyroidism in the US. TgAb is elevated in 60 to 70 percent of confirmed Hashimoto’s cases, making it useful but not universal. Some Hashimoto’s patients are TgAb-negative yet strongly TPO-positive, which is why ordering both antibodies together is standard practice. Extremely high TgAb values (hundreds to thousands of IU/mL) with concurrent TSH elevation and positive TPO are close to diagnostic on their own.
Thyroid cancer surveillance after thyroidectomy
After a total thyroidectomy for differentiated thyroid cancer (papillary or follicular), the goal is to drive thyroglobulin to undetectable levels, which confirms no residual tumor tissue. TgAb can artificially suppress the measured Tg in about 25 percent of immunoassays, making a patient’s Tg look undetectable when cancer may still be present. Any patient with post-thyroidectomy TgAb positivity needs serial TgAb measurements: a rising TgAb trend is itself a red flag for recurrence even when Tg appears low. This is one of the most clinically significant interference artifacts in all of laboratory medicine.
Graves’ disease
Graves’ is primarily diagnosed by TSH receptor antibodies (TRAb), but about 30 percent of Graves’ patients also have elevated TgAb. In this context TgAb does not change management, but its presence suggests a more complex autoimmune backdrop that may affect long-term thyroid function after treatment.
Other less common causes of elevated TgAb
- Subacute granulomatous thyroiditis (de Quervain’s), where TgAb may rise transiently during viral thyroid inflammation
- Non-thyroid autoimmune conditions: type 1 diabetes, rheumatoid arthritis, lupus, pernicious anemia
- Iodine overload or amiodarone therapy, which can trigger or unmask latent thyroid autoimmunity
- Thyroid nodules, particularly in older women, where low-level TgAb positivity is incidental about 10 percent of the time
Why TgAb quietly breaks the thyroglobulin cancer test
The single most important reason TgAb is ordered has nothing to do with diagnosing Hashimoto’s. It is that TgAb sabotages the thyroglobulin measurement used to hunt for recurrent thyroid cancer. Most labs measure thyroglobulin with an immunometric (sandwich) assay, where two lab antibodies grip the thyroglobulin molecule from both sides to generate a signal. When a patient’s own TgAb is present in the sample, it coats the thyroglobulin and physically blocks the lab antibodies from binding. The signal drops, and the reported Tg reads falsely low, sometimes undetectable, even when tumor tissue is still producing thyroglobulin.
That is the trap. A thyroid cancer patient sees an undetectable Tg and assumes they are cancer-free, while a hidden TgAb was masking a real value. This is why the standing rule in thyroid oncology is that every Tg draw must be paired with a TgAb draw on the same sample. If TgAb is positive, the lab either switches to a mass spectrometry (LC-MS/MS) method that is far less vulnerable to this interference, or the team sets the Tg number aside and tracks the TgAb trend as a stand-in tumor marker instead. A steadily rising TgAb after treatment is treated as a warning of possible recurrence, and a steadily falling TgAb is reassuring. Ordinary immunoassays also vary in how they fail: most read falsely low, but a few older competitive methods can read falsely high, which is its own kind of confusion.
TPO vs thyroglobulin antibody: which one should you test?
This is the question most primary care clinicians get wrong by defaulting to one or the other. The correct answer is both, ordered together as a thyroid antibody panel, because they are complementary rather than redundant.
| Feature | TPO antibody (TPOAb) | Thyroglobulin antibody (TgAb) |
|---|---|---|
| Target antigen | Thyroid peroxidase enzyme | Thyroglobulin protein |
| Sensitivity for Hashimoto’s | ~90% | ~60 to 70% |
| First-line for Hashimoto’s diagnosis | Yes | Second-line, adds specificity |
| Used in thyroid cancer surveillance | No (not routinely) | Yes (detects Tg assay interference) |
| Positive in Graves’ disease | ~75% | ~30% |
| General population positive rate | ~12 to 15% | ~10% |
| Clinical action when sole positive | Annual TSH monitoring | Context-dependent, often annual TSH |
TPOAb is the more sensitive marker for autoimmune thyroid disease overall. But about 5 to 10 percent of Hashimoto’s patients are TPO-negative and TgAb-positive, meaning a TPO-only strategy misses a meaningful minority. In thyroid cancer surveillance, TgAb is indispensable and TPO is irrelevant. Running both markers for roughly $5 to $20 extra in a panel is nearly always the better call than choosing one.
For anyone assembling a full picture of metabolic and immune health, a complete blood panel that includes thyroid markers gives far more context than ordering TgAb in isolation.
How the thyroglobulin antibody test is performed
This is a standard venous blood draw. No fasting is required, and time of day does not affect TgAb levels. The collected serum is run on an automated immunoassay analyzer. Results are typically available within 1 to 2 business days through Quest or Labcorp, sometimes the same day at large hospital labs.
A few logistical points that matter:
- Biotin supplementation above 5 mg per day can interfere with certain ECLIA platforms and produce falsely low TgAb results. Stop biotin at least 24 to 48 hours before the draw, or tell your clinician you take it so the lab can flag the result.
- Recent thyroid biopsy, thyroidectomy, or radioiodine ablation can temporarily spike TgAb by releasing thyroglobulin from damaged cells. Timing results at least 4 to 6 weeks after any of those procedures gives a more stable baseline.
- Pregnancy raises TgAb levels in some women, particularly in the first trimester. Post-partum thyroiditis often presents with a TgAb surge, which is worth knowing if you are evaluating new symptoms within a year of delivery.
Talk to a clinician about how to time your draw if any of these factors apply to you.
What does the thyroid antibody panel include, and when is it ordered?
A full thyroid antibody panel typically includes TSH, free T4, TPOAb, and TgAb. Some clinicians add free T3 and TSH receptor antibodies (TRAb or TSI) when Graves’ disease is in the differential. The panel is ordered in several specific clinical situations:
- Unexplained hypothyroid symptoms with normal or borderline TSH, where autoimmunity might be driving early thyroid dysfunction
- Thyroid nodule workup, since TgAb positivity increases the pre-test probability that a nodule is inflammatory rather than neoplastic
- Post-thyroidectomy surveillance for differentiated thyroid cancer, ordered at every follow-up visit
- Monitoring known Hashimoto’s during pregnancy, where autoimmune thyroid disease is the most common cause of maternal hypothyroidism and carries real fetal risk if undertreated
- Evaluating non-thyroid autoimmune conditions like type 1 diabetes or lupus, where subclinical thyroid autoimmunity is common and often overlooked
It is also reasonable to include TgAb in a comprehensive health baseline, especially for women over 35, given the high prevalence of undiagnosed Hashimoto’s in that demographic. If you are getting blood drawn anyway, it is often smarter to capture a full baseline at once. Here is how a full-body panel compares to ordering individual thyroid markers separately.
TgAb test cost: what to expect in 2026
The cash price for TgAb alone varies considerably depending on where you order it.
| Channel | Approximate cash price | Notes |
|---|---|---|
| Quest Diagnostics (direct-to-consumer) | $29 to $55 | Order online at questhealth.com, draw at a Quest PSC |
| Labcorp (direct-to-consumer) | $35 to $60 | Order at labcorpondemand.com |
| Hospital outpatient lab with insurance | $0 to $30 copay | Preventive vs. diagnostic coding affects cost share |
| CVS MinuteClinic / urgent care order | $40 to $80 office visit + lab | Convenience premium, uses Quest or Labcorp backend |
| Comprehensive thyroid panel (TSH + FT4 + TPO + TgAb bundled) | $79 to $149 cash | Panel pricing usually beats individual test pricing |
HSA and FSA dollars cover TgAb as a qualified medical expense. Medicare Part B covers the test when ordered for a Medicare-accepted diagnosis, though beneficiaries without a clear clinical indication may face cost-sharing. If you are uninsured, ordering the full thyroid panel as a bundle at Quest or Labcorp almost always costs less than ordering TgAb, TPO, TSH, and free T4 as four separate tests.
One practical note: if your clinician orders TgAb through your insurance and you have not met your deductible, you may receive a bill for the full contracted rate, which can reach $120 to $250 at some in-network hospital labs. Cash-pay through the lab’s own consumer portal often undercuts this significantly.
Comparing TgAb to other specialty biomarkers like an adiponectin test or an alkaline phosphatase test, thyroid antibodies occupy a similar mid-range price point but carry far greater clinical specificity for their target condition.
A realistic scenario: an incidental positive on a wellness panel
A 42-year-old woman with mild fatigue orders a broad wellness panel that happens to include thyroid antibodies. Her TSH comes back at 2.8 mIU/L, squarely normal, but her TgAb is 6 IU/mL, flagged positive. She is understandably alarmed, reads about Hashimoto’s overnight, and expects to start medication. In reality, this pattern is common and rarely calls for treatment. A positive antibody with a normal TSH means the autoimmune process is present but the gland is still keeping up. The correct response is not levothyroxine. It is a plan: recheck TSH and free T4 in a year, get a baseline thyroid ultrasound if she has not had one, keep iodine intake sensible rather than mega-dosed, and note that her lifetime risk of eventually needing thyroid medication is now higher than average but far from certain.
The value of the test here is not a diagnosis. It is a head start. Knowing the antibody is positive turns a future case of missed hypothyroidism into a monitored, expected transition that gets caught early. That is the honest use of an incidental positive: not a reason to panic, and not a reason to ignore it, but a reason to watch the right numbers on the right schedule.
Interpreting your TgAb result: what comes next
A positive TgAb does not automatically mean you need medication or aggressive monitoring. What happens next depends on three variables: the level, the direction of trend, and the rest of your thyroid panel.
Mildly elevated TgAb (1 to 10 IU/mL) with normal TSH and no symptoms
Most clinicians will watch this with annual TSH and free T4 rather than treating. The lifetime risk of progressing to overt hypothyroidism is real but not immediate, running roughly 2 to 4 percent per year in TPO-positive Hashimoto’s patients. Knowing the number motivates smarter lifestyle choices: adequate selenium intake (the thyroid concentrates selenium), avoiding excessive iodine supplementation, and getting a thyroid ultrasound if not done recently to assess gland volume and echotexture.
Moderately to markedly elevated TgAb (10 to hundreds of IU/mL) with TSH above 4.5 mIU/L
This pattern is consistent with active Hashimoto’s with measurable dysfunction. Most guidelines recommend levothyroxine when TSH crosses 10 mIU/L; treatment between 4.5 and 10 is individualized based on symptoms, pregnancy status, and patient preference. The TgAb level itself does not set the treatment threshold; TSH and clinical picture do.
TgAb positive in a thyroid cancer patient
This always requires discussion with an endocrinologist or thyroid oncologist. Serial TgAb measurements are used as a surrogate tumor marker. A rising trend over two or more measurements is concerning regardless of Tg value. A falling TgAb over time suggests successful treatment and reducing tumor burden.
For anyone trying to build a comprehensive picture of their immune and metabolic health, the albumin test and other hepatic markers are often ordered alongside thyroid panels to assess nutritional status, which affects thyroid hormone transport and conversion.
FAQ
What is a thyroglobulin antibody test used for?
It has two primary uses: diagnosing autoimmune thyroid disease (particularly Hashimoto’s thyroiditis) and detecting interference in thyroglobulin assays used to monitor thyroid cancer patients after thyroidectomy. A positive TgAb in cancer surveillance invalidates the Tg value on most standard immunoassays, forcing clinicians to use a more interference-resistant mass spectrometry method or track TgAb trends as a surrogate marker instead.
What is the thyroglobulin antibody normal range?
Most US laboratories define a negative result as less than 1.0 IU/mL on ECLIA platforms used by Quest and Labcorp. Older immunoturbidimetric assays use different units (up to 115 IU/mL as the upper normal). Always interpret your result against the reference range printed on your specific lab report, not a number from a different lab or platform.
Can TgAb be high without thyroid disease?
Yes. About 10 percent of healthy adults, especially women over 50, carry a mildly elevated TgAb with no evidence of thyroid dysfunction. TgAb positivity without TSH abnormality, symptoms, or TPO elevation is often incidental and requires monitoring rather than treatment. Weak positivity alone is not a diagnosis.
Should I get TPO or thyroglobulin antibody first?
Both, ordered together as a thyroid antibody panel. TPOAb is more sensitive for Hashimoto’s (positive in about 90 percent of cases), but TgAb catches the 5 to 10 percent who are TPO-negative. If your clinician orders only one and the result is negative yet your symptoms persist, ask for the other. The incremental cost is small and the diagnostic yield is real.
Does high TgAb always mean Hashimoto’s?
No. Hashimoto’s is the most common cause, but elevated TgAb also appears in Graves’ disease (in about 30 percent of patients), after thyroid injury or surgery, during subacute viral thyroiditis, and occasionally in other autoimmune conditions like lupus or type 1 diabetes. Context, clinical exam, TSH, and ideally a thyroid ultrasound are needed before concluding the cause.
How much does a TgAb test cost without insurance?
Ordered directly through Quest or Labcorp’s consumer portals, TgAb typically runs $29 to $60 cash. Bundled into a comprehensive thyroid panel with TSH, free T4, and TPO, the cost is usually $79 to $149, which is better value than four separate tests. HSA and FSA funds cover the cost. Insurance billing through a hospital outpatient lab can result in higher bills if you have not met your deductible.
Can I order a thyroglobulin antibody test without a doctor?
Yes, in most US states. Quest Diagnostics and Labcorp both offer direct-to-consumer ordering through their websites. Some states require a physician order by law, but national consumer lab portals typically handle that through a network physician at no extra charge. You receive results directly in your portal account, usually within 1 to 2 business days.
How often should TgAb be rechecked?
For incidentally elevated TgAb in an otherwise healthy person, annual rechecking alongside TSH is a reasonable interval. For Hashimoto’s patients on levothyroxine, TgAb levels do not change treatment decisions as directly as TSH and free T4, so many endocrinologists check it every 1 to 2 years rather than at every visit. In thyroid cancer surveillance, TgAb is checked at every follow-up, typically every 6 to 12 months during the first few years post-treatment.
Is there a diet that lowers thyroid antibodies?
The honest answer is that no diet reliably erases thyroid antibodies. Selenium supplementation, roughly 200 mcg daily, has shown modest antibody-lowering effects in several randomized trials in Hashimoto’s patients, though it is not a universal guideline recommendation and high-dose selenium carries its own risks over time. A gluten-free diet is heavily promoted online, and it can matter genuinely for the subset of Hashimoto’s patients who also have celiac disease, which is more common in this group, but the evidence that gluten avoidance lowers antibodies in people without celiac is weak. The most defensible dietary approach is unremarkable: adequate but not excessive iodine, enough selenium and zinc from food, and testing for and treating any coexisting celiac disease.
Do thyroid antibodies affect pregnancy?
Yes, and this is one of the more important reasons to know your TgAb and TPO status. Women who are antibody-positive have a higher risk of progressing to hypothyroidism during pregnancy, when thyroid demand rises sharply, and untreated maternal hypothyroidism carries real risk to fetal development. Antibody-positive women also face a higher rate of postpartum thyroiditis, a swing of thyroid function in the year after delivery that often gets mistaken for ordinary new-parent fatigue. If you are antibody-positive and planning pregnancy or already pregnant, thyroid function is usually monitored more closely, and treatment thresholds are lower than for non-pregnant adults.
Does TgAb go down with Hashimoto’s treatment?
Sometimes, but not reliably. Levothyroxine treats the hypothyroidism, not the underlying autoimmune process. Some patients see TgAb decline over years; others see it remain elevated or fluctuate. A falling TgAb trend is generally favorable. A stable or slowly rising TgAb without TSH change typically does not alter management. Selenium supplementation (200 mcg daily) has shown modest TgAb-lowering effects in several randomized trials in Hashimoto’s patients, though it is not a standard prescription recommendation in all US guidelines.
